TG Share Price
NASDAQ: TGTX | Mid Cap | HealthcareTG Stock Performance
TG Share Price Today
As of 21 November 2026, TG Therapeutics, Inc.'s share price is $63.35. The stock opened at $64.10, compared to its previous close of $64.85. During today's trading session, TG Therapeutics, Inc.'s share price traded between $63.19 and $65.29, with an average price of $64.24. Over the past 52 weeks, the stock has recorded a high of $67.92 and a low of $26.80. In terms of performance, TG Therapeutics, Inc.'s share price has risen by 67.00% over the last six months and is up 90.41% on a year-on-year basis.
TG Share Price Chart
TG Quarterly Profit & Loss
All figures in USD
TG Annual Profit & Loss
All figures in USD
TG Balance Sheet
All figures in USD Million
TG Cash Flow
All figures in USD Million
About TG
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.
TG Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $61.75 | $63.39 | +3.61% |
Oct 2026 | $55.53 | $61.18 | +9.46% |
Sep 2026 | $52.51 | $55.90 | +0.33% |
Aug 2026 | $50.76 | $55.71 | +7.40% |
Jul 2026 | $55.16 | $51.87 | -5.59% |
Jun 2026 | $37.57 | $54.94 | +44.83% |
May 2026 | $33.38 | $37.94 | +12.28% |
Apr 2026 | $33.33 | $33.78 | +1.78% |
Mar 2026 | $29.50 | $33.20 | +10.28% |
Feb 2026 | $29.22 | $30.10 | +2.16% |
Jan 2026 | $29.57 | $29.46 | -1.21% |
Dec 2025 | $32.41 | $29.82 | -10.35% |